{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:13:39Z","timestamp":1788952419600,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016618","name":"Gilbert Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ebiom.2026.106413","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:29:18Z","timestamp":1785565758000},"page":"106413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intratumoural plasma cells mediate a pro-inflammatory response to kinase inhibition and successful immune checkpoint blockade therapy in malignant peripheral nerve sheath tumours"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4089-9052","authenticated-orcid":false,"given":"Joshua J.","family":"Lingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altay","family":"Koyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeb R.","family":"Zacharias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Allamargot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Raygoza Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A.","family":"Kaemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jabbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor R.","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Boyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin J.","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0650-1119","authenticated-orcid":false,"given":"Patrick","family":"Breheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Meyerholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca D.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon C.D.","family":"Houtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin W.","family":"Darbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-0122","authenticated-orcid":false,"given":"Dawn E.","family":"Quelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2026.106413_bib1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11912-009-0045-z","article-title":"Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"11","author":"Widemann","year":"2009","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13311-017-0518-y","article-title":"Cancer of the peripheral nerve in neurofibromatosis type 1","volume":"14","author":"Staedtke","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ebiom.2026.106413_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.omto.2023.07.008","article-title":"The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: is there hope?","volume":"30","author":"Paudel","year":"2023","journal-title":"Mol Ther Oncolytics"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106413_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106413_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713596","article-title":"FOXM1, MEK, and CDK4\/6: new targets for malignant peripheral nerve sheath tumor therapy","volume":"24","author":"Voigt","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.18632\/oncotarget.28650","article-title":"Linking FOXM1 and PD-L1 to CDK4\/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors","volume":"15","author":"Lingo","year":"2024","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106413_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/genes11060691","article-title":"From genes to -Omics: the evolving molecular landscape of malignant peripheral nerve sheath tumor","volume":"11","author":"Lemberg","year":"2020","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib8","article-title":"Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo","volume":"4","author":"Kohlmeyer","year":"2022","journal-title":"Neuro Oncol Adv"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106413_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21083018","article-title":"CDKs in sarcoma: mediators of disease and emerging therapeutic targets","volume":"21","author":"Kohlmeyer","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18632\/oncotarget.27862","article-title":"Combination therapies for MPNSTs targeting RABL6A-RB1 signaling","volume":"12","author":"Kohlmeyer","year":"2021","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106413_bib11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ccell.2020.03.010","article-title":"Mechanisms of sensitivity and resistance to CDK4\/6 inhibition","volume":"37","author":"Alvarez-Fernandez","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-2744(199901)24:1<1::AID-MC1>3.0.CO;2-E","article-title":"ras activity and cyclin D1 expression: an essential mechanism of mouse skin tumor development","volume":"24","author":"Rodriguez-Puebla","year":"1999","journal-title":"Mol Carcinog"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106413_bib13","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1158\/1078-0432.CCR-19-2706","article-title":"RABL6A is an essential driver of MPNSTs that negatively regulates the RB1 pathway and sensitizes tumor cells to CDK4\/6 inhibitors","volume":"26","author":"Kohlmeyer","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106413_bib14","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1158\/0008-5472.CAN-17-3167","article-title":"Genomic status of MET potentiates sensitivity to MET and MEK inhibition in NF1-Related malignant peripheral nerve sheath tumors","volume":"78","author":"Peacock","year":"2018","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41698-021-00145-8","article-title":"Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor","volume":"5","author":"Nagabushan","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ebiom.2026.106413_bib16","article-title":"Preclinical assessment of MEK inhibitors for malignant peripheral nerve sheath tumors reveals differences in efficacy and adaptive response","volume":"12","author":"Gu","year":"2022","journal-title":"Front Oncol"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106413_bib17","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-20-1365","article-title":"Combined inhibition of SHP2 and MEK is effective in models of NF1-Deficient malignant peripheral nerve sheath tumors","volume":"80","author":"Wang","year":"2020","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.ebiom.2026.106413_bib18","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1158\/1078-0432.CCR-24-1750","article-title":"MEK inhibitors lead to PDGFR pathway upregulation and sensitize tumors to RAF dimer inhibitors in NF1-Deficient malignant peripheral nerve sheath tumor","volume":"30","author":"Miranda-Rom\u00e1n","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106413_bib19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1158\/1078-0432.CCR-22-3722","article-title":"MEK inhibition synergizes with TYK2 inhibitors in NF1-Associated malignant peripheral nerve sheath tumors","volume":"29","author":"Borcherding","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106413_bib20","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1158\/1078-0432.CCR-23-0749","article-title":"CDK4\/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression","volume":"29","author":"Kohlmeyer","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106413_bib21","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.7150\/thno.44871","article-title":"CDK4\/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"26","key":"10.1016\/j.ebiom.2026.106413_bib22","doi-asserted-by":"crossref","first-page":"39595","DOI":"10.18632\/oncotarget.9153","article-title":"Efficacy of the combination of MEK and CDK4\/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106413_bib23","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1158\/1535-7163.MCT-20-1126","article-title":"Targeting CDK4\/6 represents a therapeutic vulnerability in acquired BRAF\/MEK inhibitor\u2013resistant melanoma","volume":"20","author":"Nassar","year":"2021","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106413_bib24","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1158\/1535-7163.MCT-19-1016","article-title":"Metabolic adaptations to MEK and CDK4\/6 cotargeting in uveal melanoma","volume":"19","author":"Teh","year":"2020","journal-title":"Mol Cancer Ther"},{"issue":"6421","key":"10.1016\/j.ebiom.2026.106413_bib25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.aas9090","article-title":"NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination","volume":"362","author":"Ruscetti","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cell.2020.03.008","article-title":"Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer","volume":"181","author":"Ruscetti","year":"2020","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106413_bib27","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","article-title":"Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer","volume":"24","author":"Wouters","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106413_bib28","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-Cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106413_bib29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"7791","key":"10.1016\/j.ebiom.2026.106413_bib30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2026.106413_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1256355","article-title":"The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers","volume":"14","author":"Yu","year":"2023","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106413_bib32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106413_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"issue":"7791","key":"10.1016\/j.ebiom.2026.106413_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2026.106413_bib35","article-title":"Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106413_bib36","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.4049\/jimmunol.178.4.2192","article-title":"AID-\/-mus-\/- mice are agammaglobulinemic and fail to maintain B220-CD138+ plasma cells","volume":"178","author":"Kumazaki","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101402","article-title":"Mouse splenocyte enrichment strategies via negative selection for broadened single-cell transcriptomics","volume":"3","author":"Schulze","year":"2022","journal-title":"STAR Protoc"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106413_bib38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41374-018-0057-0","article-title":"Principles and approaches for reproducible scoring of tissue stains in research","volume":"98","author":"Meyerholz","year":"2018","journal-title":"Lab Invest"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106413_bib39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cyto.a.24788","article-title":"OMIP-095: 40-color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues","volume":"103","author":"Kare","year":"2023","journal-title":"Cytometry A"},{"key":"10.1016\/j.ebiom.2026.106413_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.794684","article-title":"B cells are required to generate optimal anti-melanoma immunity in response to checkpoint blockade","volume":"13","author":"Singh","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib41","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1038\/s41467-019-12160-2","article-title":"B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma","volume":"10","author":"Griss","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106413_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/genes11050583","article-title":"Distinct tumor microenvironments are a defining feature of strain-specific CRISPR\/Cas9-Induced MPNSTs","volume":"11","author":"Scherer","year":"2020","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17900-3","article-title":"A clustering-independent method for finding differentially expressed genes in single-cell transcriptome data","volume":"11","author":"Vandenbon","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell\u2013cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat Protoc"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106413_bib45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41577-018-0007-5","article-title":"Understanding the drivers of MHC restriction of T cell receptors","volume":"18","author":"La Gruta","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106413_bib46","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-Cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106413_bib47","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.18632\/oncotarget.3205","article-title":"Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration","volume":"6","author":"Zumwalt","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001136","article-title":"CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer","volume":"9","author":"Yang","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005545","article-title":"Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity","volume":"11","author":"Sorin","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2118210","article-title":"CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy","volume":"11","author":"Li","year":"2022","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/cancers14020294","article-title":"Potential role of CXCL13\/CXCR5 signaling in immune checkpoint inhibitor treatment in cancer","volume":"14","author":"Hsieh","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2026.106413_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/587259","article-title":"Molecular biomarkers of response to antiangiogenic therapy for cancer","volume":"2012","author":"Duda","year":"2012","journal-title":"ISRN Cell Biol"},{"key":"10.1016\/j.ebiom.2026.106413_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.581615","article-title":"FCGR1A serves as a novel biomarker and correlates with immune infiltration in four cancer types","volume":"7","author":"Xu","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106413_bib55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccell.2015.08.004","article-title":"Fc\u03b3Rs modulate the anti-tumor activity of antibodies targeting the PD-1\/PD-L1 axis","volume":"28","author":"Dahan","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib57","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1364828","article-title":"PD-1 expression on tumor-specific T cells: friend or foe for immunotherapy?","volume":"7","author":"Simon","year":"2018","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106413_bib59","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.4049\/jimmunol.1202395","article-title":"CD62L is critical for maturation and accumulation of murine hepatic NK cells in response to viral infection","volume":"190","author":"Peng","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1747340","article-title":"Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas","volume":"9","author":"Dancsok","year":"2020","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106413_bib61","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1158\/1078-0432.CCR-13-2576","article-title":"Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs","volume":"20","author":"Patwardhan","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2026.106413_bib62","first-page":"i23","article-title":"After Nf1 loss in schwann cells, inflammation drives neurofibroma formation","volume":"2","author":"Fletcher","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"15","key":"10.1016\/j.ebiom.2026.106413_bib63","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/1078-0432.CCR-19-3416","article-title":"The immunosuppressive niche of soft-tissue sarcomas is sustained by tumor-associated macrophages and characterized by intratumoral tertiary lymphoid structures","volume":"26","author":"Chen","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000764","article-title":"Tumors establish resistance to immunotherapy by regulating Tregrecruitment via CCR4","volume":"8","author":"Marshall","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1199","article-title":"Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): a novel population in the tumour microenvironment and immunotherapy target","volume":"13","author":"Li","year":"2023","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.anai.2019.10.008","article-title":"The role of filaggrin in atopic dermatitis and allergic disease","volume":"124","author":"Drislane","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106413_bib67","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.21037\/tau-22-573","article-title":"Analysis of prognostic oncogene filaggrin (FLG) wild-type subtype and its implications for immune checkpoint blockade therapy in bladder urothelial carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13104-022-06100-5","article-title":"Utility of CD138\/syndecan-1 immunohistochemistry for localization of plasmacytes is tissue-dependent in B6 mice","volume":"15","author":"Meyerholz","year":"2022","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ebiom.2026.106413_bib69","series-title":"Profiling tumor infiltrating immune cells with CIBERSORT","first-page":"243","author":"Chen","year":"2018"},{"key":"10.1016\/j.ebiom.2026.106413_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00788","article-title":"In the right place, at the right time: Spatiotemporal conditions determining plasma cell survival and function","volume":"10","author":"Lindquist","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106413_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954936","article-title":"Role of B cells as antigen presenting cells","volume":"13","author":"Rastogi","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106413_bib72","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41590-023-01712-w","article-title":"Unraveling the diversity and functions of tissue-resident plasma cells","volume":"25","author":"Tellier","year":"2024","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106413_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.AID-0019-2014","article-title":"Functions of antibodies","volume":"2","author":"Forthal","year":"2014","journal-title":"Microb Spectr"},{"key":"10.1016\/j.ebiom.2026.106413_bib74","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","article-title":"NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy","volume":"6","author":"Wang","year":"2015","journal-title":"Front Immunol"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106413_bib75","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.3390\/ijms22168947","article-title":"The role of Fc receptors on the effectiveness of therapeutic monoclonal antibodies","volume":"22","author":"Gogesch","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106413_bib76","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20112142","article-title":"Macrophages induce differentiation of plasma cells through CXCL10\/IP-10","volume":"209","author":"Xu","year":"2012","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106413_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16050994","article-title":"The NF1+\/- immune microenvironment: dueling roles in neurofibroma development and malignant transformation","volume":"16","author":"White","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106413_bib78","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1158\/1535-7163.MCT-23-0833","article-title":"Trametinib potentiates Anti-PD-1 efficacy in tumors established from chemotherapy-primed pancreatic cancer cells","volume":"23","author":"Pham","year":"2024","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106413_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181671","article-title":"Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallenge","volume":"135","author":"Qin","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2026.106413_bib80","article-title":"Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.ebiom.2026.106413_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213998","article-title":"Integrative and comprehensive pan-cancer analysis of lymphocyte-specific protein tyrosine kinase in human tumors","volume":"23","author":"Han","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106413_bib82","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells","volume":"161","author":"Thomas","year":"1998","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106413_bib83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106413_bib84","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1158\/1078-0432.CCR-16-2811","article-title":"Involvement of c-Fos in the promotion of cancer stem-like cell properties in head and neck squamous cell carcinoma","volume":"23","author":"Muhammad","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106413_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65945-x","article-title":"DUSP1 and SOX2 expression determine squamous cell carcinoma of the salivary gland progression","volume":"14","author":"Acero-Riaguas","year":"2024","journal-title":"Sci Rep"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106413_bib86","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1158\/0008-5472.CAN-11-3490","article-title":"The MET oncogene is a functional marker of a glioblastoma stem cell subtype","volume":"72","author":"De Bacco","year":"2012","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106413_bib87","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/1078-0432.CCR-07-1305","article-title":"High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization","volume":"14","author":"Mantripragada","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106413_bib88","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.celrep.2018.02.053","article-title":"The CDK4\/6 inhibitor abemaciclib induces a T cell inflamed tumor microenvironment and enhances the efficacy of PD-L1 checkpoint blockade","volume":"22","author":"Schaer","year":"2018","journal-title":"Cell Rep"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:32:12Z","timestamp":1788949932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":88,"alternative-id":["S2352396426002975"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106413","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratumoural plasma cells mediate a pro-inflammatory response to kinase inhibition and successful immune checkpoint blockade therapy in malignant peripheral nerve sheath tumours","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106413"}}